Gene · 6548
Papers3,457
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,457
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer. | Breast Cancer Res | 2023 | 37098526 | PubTator, text mining | PubMed |
| Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms. | Cardiovasc Diabetol | 2023 | 37055837 | PubTator, text mining | PubMed |
| Novel differential calcium regulation of hematopoietic stem and progenitor cells under physiological low oxygen conditions. | J Cell Physiol | 2023 | 37051890 | PubTator, text mining | PubMed |
| Spider venom-derived peptide JZTX-14 prevents migration and invasion of breast cancer cells via inhibition of sodium channels. | Front Pharmacol | 2023 | 37033662 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| An atlas of genetic scores to predict multi-omic traits. | Nature | 2023 | 36991119 | PubTator, text mining | PubMed |
| Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis. | Cancer Res | 2023 | 36989344 | PubTator, text mining | PubMed |
| Understanding the Mechanisms and Treatment of Heart Failure: Quantitative Systems Pharmacology Models with a Focus on SGLT2 Inhibitors and Sex-Specific Differences. | Pharmaceutics | 2023 | 36986862 | PubTator, text mining | PubMed |
| The SLC9C2 Gene Product (Na+/H+ Exchanger Isoform 11; NHE11) Is a Testis-Specific Protein Localized to the Head of Mature Mammalian Sperm. | Int J Mol Sci | 2023 | 36982403 | PubTator, text mining | PubMed |
| Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms. | Int J Mol Sci | 2023 | 36982204 | PubTator, text mining | PubMed |
| New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy. | Int J Mol Sci | 2023 | 36982164 | PubTator, text mining | PubMed |
| Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry Disease. | Diagnostics (Basel) | 2023 | 36980460 | PubTator, text mining | PubMed |
| Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice. | Biomedicines | 2023 | 36979641 | PubTator, text mining | PubMed |
| Skin-Interfaced Wearable Sweat Sensors for Precision Medicine. | Chem Rev | 2023 | 36971504 | PubTator, text mining | PubMed |
| Systematic review of sodium-glucose cotransporter 2 inhibitors: a hopeful prospect in tackling heart failure-related events. | ESC Heart Fail | 2023 | 36967133 | PubTator, text mining | PubMed |
| Signaling pathway mechanisms of neurological diseases induced by G protein-coupled receptor 39. | CNS Neurosci Ther | 2023 | 36942516 | PubTator, text mining | PubMed |
| A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor-positive disease. | Cancer Med | 2023 | 36938826 | PubTator, text mining | PubMed |
| Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets. | Hepatol Commun | 2023 | 36930869 | PubTator, text mining | PubMed |
| Hypoxia enhances interactions between Na+/H+ exchanger isoform 1 and actin filaments via ezrin in pulmonary vascular smooth muscle. | Front Physiol | 2023 | 36926194 | PubTator, text mining | PubMed |
| Antifungal activity of 6-substituted amiloride and hexamethylene amiloride (HMA) analogs. | Front Cell Infect Microbiol | 2023 | 36923593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6548/papers?page=15